CSS LLC’s Amicus Therapeutics FOLD Stock Holding History

CSS LLC’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,500	Closed	-$484K	–	1091
2026 Q1	$484K	Buy	+33,500	New	+$480K	0.02%	534
2021 Q1	–	Sell	-20,231	Closed	-$467K	–	976
2020 Q4	$467K	Buy	20,231 +5,000	+33%	+$102K	0.02%	477
2020 Q3	$215K	Buy	+15,231	New	+$222K	0.01%	562
2020 Q1	–	Sell	-22,731	Closed	-$221K	–	666
2019 Q4	$221K	Sell	22,731 -7,500	-25%	-$68.7K	0.01%	489
2019 Q3	$242K	Sell	30,231 -25,901	-46%	-$281K	0.02%	418
2019 Q2	$701K	Buy	56,132 +54,839	+4,241%	+$696K	0.04%	272
2019 Q1	$18K	Buy	+1,293	New	+$15.8K	﹤0.01%	513

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CSS LLC's FOLD Position: Q2 2026 in Review

CSS LLC sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 33,500 shares — an estimated $484K sold.

CSS LLC first reported a position in FOLD in Q1 2019 and held it in 7 quarters. The position peaked at $701K in Q2 2019. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

CSS LLC reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
CSS LLC sold 33,500 Amicus Therapeutics shares in Q2 2026, an estimated $484K.
CSS LLC first reported a position in Amicus Therapeutics in Q1 2019 and held it in 7 quarters.
CSS LLC's Amicus Therapeutics position peaked at $701K in Q2 2019.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.